Effectiveness of Exercise Therapy Versus Spinal Manual Therapy in Patients With PFPS (NCT04748692) | Clinical Trial Compass
CompletedNot Applicable
Effectiveness of Exercise Therapy Versus Spinal Manual Therapy in Patients With PFPS
43 participantsStarted 2016-10-01
Plain-language summary
Preliminary results of a pilot study in The Bergman Clinic Naarden (NL) show that a local exercise therapy group may decrease pain by 30% on the visual analogue scale (VAS) after 6 weeks. A reduction of 50% on the VAS was realized in a spinal manual therapy group. Therefore, the aim of this study is to compare the effectiveness of local exercise therapy versus spinal manual therapy in patients with PFPS after 6 weeks of intervention and at 6 weeks of follow-up. To the knowledge of the authors, the clinical effectiveness of spinal manual manipulations on pain, function and strength has not been investigated in the medium term.
Who can participate
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* self-reported unilateral or
* bilateral anterior knee pain provoked by at least two of the following activities: jumping, squatting, ascending/ descending stairs, kneeling, prolonged sitting and or a
* positive patellar compression test
Exclusion Criteria:
* experiencing pain for less than 3 months
* a history of knee surgery
* meniscal lesion
* patellar subluxation/dislocation
* evidence of tendinopathy or ligamentous pathologies
* dislocation or fracture in the pelvic region
* spinal surgery
* osteoporosis
* pregnancy
* neurologic disorders
* findings of chondromalacia \> grade 2 on MRI, echography or X-ray.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual analogue scale
Timeframe: before the first intervention (at baseline)
2
Visual analogue scale
Timeframe: 6 weeks after the first intervention (at 6 weeks)
3
Visual analogue scale
Timeframe: 6 weeks after the last intervention (at 12 weeks)
4
Functionality
Timeframe: before the first intervention (baseline)
5
Functionality
Timeframe: 6 weeks after the first intervention (at 6 weeks)
6
Functionality
Timeframe: 6 weeks after the last intervention (at 12 weeks)